Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County

Familial Cancer

Volumn 5, Issue 4, 2006, Pages 309-321

  Margolin, Sara ^a   Johansson, Hemming ^a   Rutqvist, Lars Erik ^a   Lindblom, Annika ^b   Fornander, Tommy ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer; Family history; Population based; Prognosis

Indexed keywords

HORMONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; OVARY CANCER; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RECURRENCE RISK; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PROGNOSIS; RECEPTORS, ESTROGEN;

EID: 33749317451     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-006-7851-3     Document Type: Article

References (53)

1. Socialstyrelsen (2002) Epidemiologiskt centrum., Medicinalstyrelsen. and Socialstyrelsen. Cancerregistret. Cancer incidence in Sweden. Socialstyrelsen, Statistik. Hälsa och sjukdomar, Stockholm
2. Newman B, Austin MA, Lee M, King MC (1988) Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 85:3044-3048
3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
4. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090
5. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689
6. Malkin D (1994) p53 and the Li-Fraumeni syndrome. Biochim Biophys Acta 1198:197-213
7. Eng C (1998) Genetics of Cowden syndrome: through the looking glass of oncology. Int J Oncol 12:701-710
8. Boardman LA, Thibodeau SN, Schaid DJ, Lindor NM, McDonnell SK, Burgart LJ, Ahlquist DA, Podratz KC, Pittelkow M, Hartmann LC (1998) Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 128:896-899
9. Swift M, Reitnauer PJ, Morrell D, Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289-1294
10. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71:800-809
11. Weber BL, Nathanson KL (2000) Low penetrance genes associated with increased risk for breast cancer. Eur J Cancer 36:1193-1199
12. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:843-854
13. Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21:1-18
14. Adami HO, Hansen J, Jung B, Rimsten A (1980) Familiality in breast cancer: a case-control study in a Sweden population. Br J Cancer 42:71-77
15. Lynch HT, Lynch JF (1986) Breast cancer genetics in an oncology clinic: 328 consecutive patients. Cancer Genet Cytogenet 22:369-371
16. Lindblom A, Rotstein S, Larsson C, Nordenskjold M, Iselius L (1993) Hereditary breast cancer in Sweden: a predominance of maternally inherited cases. Breast Cancer Res Treat 24:159-165
17. Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J (1994) The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 179:29-32
18. Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H (2000) Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 36:1143-1148
19. Doepel M, Kellokumpu IH, v Smitten KA (1995) Hereditary breast cancer in Finnish women. Eur J Surg 161:805-809
20. Pharoah PD, Lipscombe JM, Redman KL, Day NE, Easton DF, Ponder BA (2000) Familial predisposition to breast cancer in a British population: implications for prevention. Eur J Cancer 36:773-779
21. Tsuchiya A, Kanno M, Nomizu T, Hatakeyama Y, Kimijima I, Abe R (1998) Clinical characteristics of breast cancer patients with family history. Fukushima J Med Sci 44:35-41
22. Wobbes T, van de Wiel MP, van der Sluis RF, Theeuwes AG (1987) The effect of familiality on clinical presentation and survival in mammary carcinoma. Eur J Surg Oncol l13:119-121
23. Russo A, Herd-Smith A, Gestri D, Bianchi S, Vezzosi V, Rosselli Del Turco M, Cardona G (2002) Does family history influence survival in breast cancer cases? Int J Cancer 99:427-430
24. Molino A, Giovannini M, Pedersini R, Frisinghelli M, Micciolo R, Mandara M, Pavarana M, Cetto GL (2004) Correlations between family history and cancer characteristics in 2256 breast cancer patients. Br J Cancer 91:96-98
25. Anderson DE (1971) Some characteristics of familial breast cancer. Cancer 28:1500-1504
26. Adami HO, Hansen J, Jung B, Rimsten A (1981) Characteristics of familial breast cancer in Sweden: absence of relation to age and unilateral versus bilateral disease. Cancer 48:1688-1695
27. Loman N, Johannsson O, Bendahl PO, Borg A, Ferno M, Olsson H (1998) Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83:310-319
28. Pathology of familial breast cancer (1997) differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 349:1505-1510
29. Chappuis PO, Rosenblatt J, Foulkes WD (1999) The influence of familial and hereditary factors on the prognosis of breast cancer. Ann Oncol 10:1163-1170
30. Thalib L, Wedren S, Granath F, Adami HO, Rydh B, Magnusson C, Hall P (2004) Breast cancer prognosis in relation to family history of breast and ovarian cancer. Br J Cancer 90:1378-1381
31. Kinoshita T, Fukutomi T, Iwamoto E, Akashi-Tanaka S (2004) Prognosis of breast cancer patients with familial history classified according to their menopausal status. Br J Cancer 10:218-222
32. Magnusson C, Colditz G, Rosner B, Bergstrom R, Persson I (1998) Association of family history and other risk factors with breast cancer risk (Sweden). Cancer Causes Control 9:259-267
33. Olsson H, Bladstrom A (2002) A cohort study of reproductive factors and family history of breast cancer in southern Sweden. Breast Cancer Res Treat 76:203-209
34. Jernstrom HC, Johannsson OT, Loman N, Borg A, Olsson H (1999) Reproductive factors in hereditary breast cancer. Breast Cancer Res Treat 58:295-301
35. Colditz GA, Rosner BA, Speizer FE (1996) Risk factors for breast cancer according to family history of breast cancer. For the Nurses' Health Study Research Group. J Natl Cancer Inst 88:365-371
36. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410
37. Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013-1020
38. Arver B, Borg A, Lindblom A (2001) First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm. Genet Test 5:1-8
39. Arver B, Claro A, Langerod A, Borresen-Dale AL, Lindblom A (1999) BRCA1 screening in patients with a family history of breast or ovarian cancer. Genet Test 3:223-226
40. Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, Sandelin K, Hakansson S, Andersen TI, Borg A, Borresen Dale AL, Lindblom A (1997) A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res 57:2474-2477
41. Chen J, Hedman MZ, Arver BW, Sigurdsson S, Eyfjord JE, Lindblom A (1998) BRCA2 germline mutations in Swedish breast cancer families. Eur J Hum Genet 6:134-139
42. Mattsson B, Rutqvist LE, Wallgren A (1985) Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol 14:64-69
43. Margolin S, Werelius B, Fornander T, Lindblom A (2004) BRCA1 mutations in a population-based study of breast cancer in Stockholm County. Genet Test 8:127-132
44. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943-949
45. Hutson SP (2003) Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk. Oncol Nurs Forum 30:241-246
46. Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324
47. Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73:643-651
48. Theis B, Boyd N, Lockwood G, Tritchler D (1994) Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 3:321-327
49. Mohammed SN, Smith P, Hodgson SV, Fentiman IS, Miles DW, Barnes DM, Millis RR, Rubens RD (1998) Family history and survival in premenopausal breast cancer. Br J Cancer 77:2252-2256
50. Vårdprogram Ba, Onkologiskt Centrum Stockholm-Gotland
51. Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G, Ach R, Loman N, Olsson H, Meltzer P, Borg A, Trent J (2003) Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci USA 100:2532-2537
52. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85
53. Peto J, Mack TM (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26:411-414